BPC 10mg+TB10mg – 20mg (10 vials)

BPC-157 10mg + TB-500 10mg – 20mg – 10 Vials

Product Overview

This combination product is listed as containing BPC-157 and TB-500, two synthetic peptides associated with research into cellular biology and tissue-related processes.

BPC-157 is a synthetic peptide investigated primarily in preclinical studies. TB-500 is a commercial designation commonly associated with thymosin beta-4-related research, although the exact composition of commercial products should be verified with the supplier.

The combination is intended for research identification purposes. Research interest in either compound does not establish that this specific combination is safe or effective for human therapeutic use.

Product Details

• Product Name: BPC-157 + TB-500
• BPC-157 Listed Strength: 10mg
• TB-500 Listed Strength: 10mg
• Combined Listed Amount: 20mg
• Package Quantity: 10 vials
• Product Category: Synthetic Peptide Combination
• Research Areas: Peptide biology and cellular processes
• Manufacturer: Confirm with supplier
• Formulation: Confirm with supplier
• Storage Requirements: Follow verified manufacturer documentation

Scientific Background

BPC-157

BPC-157 is a synthetic peptide that has been explored in preclinical research involving various biological processes. Findings from experimental models should not be presented as proof of clinical benefits or safety in humans.

TB-500

TB-500 is a commercial name commonly associated with thymosin beta-4-related research. Commercial products may differ in composition, so the exact peptide sequence and ingredient identity should be confirmed before making specific scientific claims.

Product Verification

Before publishing or distributing this product, confirm:

• Whether each vial contains 10mg of BPC-157 and 10mg of TB-500
• Whether the combined 20mg amount applies to each vial
• The exact identity and sequence of the TB-500 ingredient
• Manufacturer identity and product labeling
• Batch identification and available quality documentation
• Storage and handling requirements
• Applicable regulatory status and distribution requirements

Important Safety and Regulatory Information

BPC-157 and TB-500 should be treated as investigational research compounds. Their safety and effectiveness for therapeutic human use have not been established sufficiently to present them as approved treatments.

This description is for product identification and general research information only. It is not medical advice, a dosing guide, or a recommendation for human administration. Avoid unsupported claims about healing, injury recovery, or other clinical benefits. Verify the product’s identity and regulatory status before publication.